Gülşah Bayraktar obtained her bachelor’s degree from the Faculty of Pharmacy at Ege University. She later received her PhD in Pharmaceutical Chemistry from the same institution in 2019. Her doctoral research focused on the design and synthesis of MTDLs for the treatment of Alzheimer’s disease.
During her PhD and postdoctoral research, Dr. Bayraktar broadened her scientific perspective through internationally funded stays in Europe, including laboratories at the University of Nantes (Prof. Marchand), Julius‑Maximilian University of Würzburg (Prof. Holzgrabe), and the University of Bologna (Prof. Bolognesi). These experiences enhanced her expertise in synthetic organic chemistry and facilitated productive collaborations across several research networks.
Since her PhD studies, Dr. Bayraktar has broadened her research interests to include neglected tropical diseases. In line with her expertise, she is the Working Group 5 - Promoting Dissemination Leader of Cost Action ‘One Health drugs against parasitic vector borne diseases in Europe and beyond’. Additionally, Dr. Bayraktar serves as National Point of Contact in GP2A.
Dr. Bayraktar currently works as an Assistant Professor in the Department of Pharmaceutical Chemistry at Ege University’s Faculty of Pharmacy in İzmir, Türkiye and specializes in the rational design and synthesis of small molecules targeting neurodegenerative disorders and neglected tropical diseases.
Gülşah Bayraktar obtained her bachelor’s degree from the Faculty of Pharmacy at Ege University. She later received her PhD in Pharmaceutical Chemistry from the same institution in 2019. Her doctoral research focused on the design and synthesis of MTDLs for the treatment of Alzheimer’s disease.
During her PhD and postdoctoral research, Dr. Bayraktar broadened her scientific perspective through internationally funded stays in Europe, including laboratories at the University of Nantes (Prof. Marchand), Julius‑Maximilian University of Würzburg (Prof. Holzgrabe), and the University of Bologna (Prof. Bolognesi). These experiences enhanced her expertise in synthetic organic chemistry and facilitated productive collaborations across several research networks.
Since her PhD studies, Dr. Bayraktar has broadened her research interests to include neglected tropical diseases. In line with her expertise, she is the Working Group 5 - Promoting Dissemination Leader of Cost Action ‘One Health drugs against parasitic vector borne diseases in Europe and beyond’. Additionally, Dr. Bayraktar serves as National Point of Contact in GP2A.
Dr. Bayraktar currently works as an Assistant Professor in the Department of Pharmaceutical Chemistry at Ege University’s Faculty of Pharmacy in İzmir, Türkiye and specializes in the rational design and synthesis of small molecules targeting neurodegenerative disorders and neglected tropical diseases.